Discover
MIST
Milestone Pharmaceuticals Inc.
1.16
2 x 0.84
2 x 1.48
bid
ask
+
0.00
0.00%
2 @ 07:48 PM
1.16 +0.00 (0.01%)
| Ytd | -42.57% | |
| 1y | -36.96% |
1.14
day range
1.17
1.00
52 week range
3.06
| Open | 1.17 | Prev Close | 1.16 | Low | 1.14 | High | 1.17 | Mkt Cap | 144.42M |
| Vol | 1.00M | Avg Vol | 1.43M | EPS | -0.65 | P/E | N/A | Forward P/E | -2.15 |
| Beta | 1.73 | Short Ratio | 2.46 | Inst. Own | 57.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 1.19 | 200-d Avg | 1.68 | 1yr Est | 10.25 |
| Income Statement | |||
| Total Revenue | 559.00K | ||
| Revenues (USD) | 559.00K | ||
| Cost of Revenue | 32.00K | ||
| Gross Profit | 527.00K | ||
| Operating Expenses | 26.16M | ||
| Research and Development Expense | 3.51M | ||
| Selling, General and Administrative Expense | 22.65M | ||
| Operating Income | -25.63M | ||
| Interest Expense | 4.72M | ||
| Net Income | -28.61M | ||
| Net Income Common Stock | -28.61M | ||
| Net Income Common Stock (USD) | -28.61M | ||
| Consolidated Income | -28.61M | ||
| Earnings per Basic Share | -0.21 | ||
| Earnings per Basic Share (USD) | -0.21 | ||
| Earnings per Diluted Share | -0.21 | ||
| Earning Before Interest & Taxes (EBIT) | -23.89M | ||
| Earning Before Interest & Taxes (USD) | -23.89M | ||
| Weighted Average Shares | 138.69M | ||
| Weighted Average Shares Diluted | 138.69M | ||
| Balance Sheet | |||
| Cash and Equivalents | 169.73M | ||
| Cash and Equivalents (USD) | 169.73M | ||
| Investments | 881.00K | ||
| Investments Current | 881.00K | ||
| Trade and Non-Trade Receivables | 3.45M | ||
| Current Assets | 180.33M | ||
| Property, Plant & Equipment Net | 1.30M | ||
| Total Assets | 181.63M | ||
| Debt Current | 670.00K | ||
| Total Debt | 141.83M | ||
| Current Liabilities | 22.18M | ||
| Debt Non-Current | 141.16M | ||
| Total Liabilities | 163.41M | ||
| Accumulated Retained Earnings (Deficit) | -485.28M | ||
| Shareholders Equity | 18.22M | ||
| Shareholders Equity (USD) | 18.22M | ||
| Assets Non-Current | 1.30M | ||
| Total Debt (USD) | 141.83M | ||
| Deferred Revenue | 1.03M | ||
| Inventory | 4.72M | ||
| Liabilities Non-Current | 141.22M | ||
| Trade and Non-Trade Payables | 8.45M | ||
| Tax Assets | 515.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 57.00K | ||
| Net Cash Flow from Financing | 9.13M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 98.41M | ||
| Capital Expenditure | -26.00K | ||
| Issuance (Purchase) of Equity Shares | 9.14M | ||
| Issuance (Repayment) of Debt Securities | -11.00K | ||
| Net Cash Flow from Investing | 111.99M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 112.02M | ||
| Net Cash Flow from Operations | -22.71M | ||
| Share Based Compensation | 1.34M | ||